Annual Reports

 
Quarterly Reports

 
8-K

 
Other

Paratek Pharmaceuticals, Inc. 8-K 2009

Documents found in this filing:

  1. 8-K
  2. 8-K
Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

June 18, 2009 (June 16, 2009)

Date of Report (date of earliest event reported)

 

 

TRANSCEPT PHARMACEUTICALS, INC.

(Exact name of Registrant as specified in its charter)

 

 

 

Delaware   000-51967   33-0960223

(State or other jurisdiction of

incorporation or organization)

  (Commission File Number)  

(I.R.S. Employer

Identification Number)

1003 W. Cutting Blvd., Suite #110

Point Richmond, California 94804

(Address of principal executive offices)

(510) 215-3500

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 1.01 Entry into a Material Definitive Agreement

On June 16, 2009, Transcept Pharmaceuticals, Inc., a Delaware corporation (the “Sublessor”), entered into a sublease agreement dated for reference purposes as of June 11, 2009 (the “Sublease”) with Bay Area Bioscience Association, a California corporation (the “Sublessee”), for office space consisting of 6,920 square feet (the “Subleased Premises”) of Sublessor’s 25,288 total leased square footage at 400 Oyster Point Boulevard, Suite 200, South San Francisco, California.

The term of the Sublease commences on July 1, 2009 and ends on October 31, 2012. Sublessee does not have the option of extending the term of the Sublease. Notwithstanding the foregoing, both Sublessor’s and Sublessee’s obligations under the Sublease are conditioned upon receipt by Sublessor from Kashiwa Fudosan America, Inc., a California corporation (the “Master Lessor”), of Master Lessor’s written consent to the Sublease.

The total base rent payable by Sublessee to Sublessor through the end of the term of the Sublease is approximately $367,000. Sublessee is also obligated under the Sublease to deposit with Sublessor a security deposit in the amount of $12,500, in cash or in the form of an irrevocable standby letter of credit.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

      TRANSCEPT PHARMACEUTICALS, INC.
Date: June 18, 2009      
      By:  

/s/    Marilyn E. Wortzman

      Name:   Marilyn E. Wortzman
      Title:   Vice President, Finance

 

-2-

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki